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The metabolic interactions and signaling between neurons and glial cells are necessary for
the development and maintenance of brain functions and structures and for neuroprotec-
tion, which includes protection from chemical attack. Astrocytes are essential for cerebral
detoxification and present an efficient and specific cytochrome P450 enzymatic system.
Whilst Crotalaria (Fabaceae, Leguminosae) plants are used in popular medicine, they are
considered toxic and can cause damage to livestock and human health problems. Studies in
animals have shown cases of poisoning by plants from the genus Crotalaria, which induced
damage to the central nervous system.This finding has been attributed to the toxic effects
of the pyrrolizidine alkaloid (PA) monocrotaline (MCT). The involvement of P450 enzymatic
systems in MCT hepatic and pulmonary metabolism and toxicity has been elucidated, but
little is known about the pathways implicated in the bioactivation of these systems and the
direct contribution of these systems to brain toxicity.This review will present the main tox-
icological aspects of the Crotalaria genus that are established in the literature and recent
findings describing the mechanisms involved in the neurotoxic effects of MCT, which was
extracted from Crotalaria retusa, and its interaction with neurons in isolated astrocytes.
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NEUROTOXIC PLANTS OF VETERINARY AND HUMAN
INTEREST
In natural conditions, poisonous plants are introduced into the
body of man or domestic animals and are capable of causing dam-
age, which is reflected in the health and vitality of these beings.
They cause an imbalance, which results in symptoms of intoxica-
tion in the patient. The toxic agent of a plant consists of a substance
or a set of chemically well-defined substances, and the latter are
of the same nature or different. When these substances contact
the body, they are capable of causing intoxication. When poiso-
nous plants are eaten by herbivores, many of them share space
with grass, or they can be eaten accidentally by humans; the con-
sumption of poisonous plants can result in nerve disturbances
in the human digestive tract and heart and in some cases, lead
to death. In Brazil, because data on the frequency and causes of
mortality from some states are lacking, it is difficult to estimate
losses due to the death of animals. According to Riet-Correa and
Medeiros (2001), in the states of Rio Grande do Sul and Santa
Catarina, the annual mortality rate of cattle caused by toxic plants
is 10–14%. With regard to arid regions of the country, the situ-
ation is more severe during periods when food is scarce because
animals tend to eat what is available. In those regions, the annual
mortality rate is 7.2%. In Brazil, the resulting impact on animal
production amounts to millions of dollars. Another important
aspect related to the ingestion of toxic plants by animals is that the
toxins can be transferred to humans through the consumption of
milk, meat, eggs, or other animal products. It is well known that
in the United States, the consumption of milk produced by cows
that are maintained in pastures invaded by Eupatorium rugosum
causes a disease condition known as “milk sickness,” which may
result in human death (Panter and James, 1990). Other toxins in
milk include pyrrolizidine alkaloids, which are present in plants
from the genera Senecio, Heliotropium, Echium, Amsinckia, Sym-
phytum (comfrey), Cynoglossum (hound’s tongue), and Festuca
(tall fescue) and are abundant in plants from the genus Crotalaria
(Dickinson et al., 1976; Panter and James, 1990). In Brazil, the
milk from goats fed with Crotalaria spectabilis was toxic to rats
(Medeiros et al., 1999), and litters of rats fed with C. spectabilis
or monocrotaline (MCT), the main pyrrolizidine alkaloid, had
poisoned milk (Medeiros et al., 1998). Plants that have been con-
sidered neurotoxic are described in Table 1 and include the genera
Ipomoea, Ricinus, Phalaris, Solanum, Prosopis, and Crotalaria.
ASTROCYTES: AN EFFICIENT SYSTEM FOR DETOXIFICATION
AND BIOACTIVATION IN THE CNS
The metabolic interactions and signaling between neurons and
glial cells have been previously described. These intimate inter-
actions are necessary for the development and maintenance of
brain functions and structures and for neuroprotection, which
includes protection induced by chemical attack (Tardy, 2002; Eskes
et al., 2003; Zurich et al., 2004). The interrelationships between
neural and glial cells contribute to the development, function, and
reparative capacity of the brain and can participate in its dete-
rioration due to aging or disease (for review see Tardy, 2002,
and Sofroniew and Vinters, 2010). In the Central Nervous Sys-
tem (CNS), astrocytes, and microglia are the two cell populations
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Table 1 | Plants that have been considered as neurotoxic and toxic
metabolites.
Plant species Neurotoxic metabolite Reference
Crotalaria Monocrotaline and
tricodesmine (alkaloids)
Riet-Correa et al. (2011)
C. spectabilis
C. crispate
C. dura
C. mucronata
C. retusa
Ipomoea asarifolia Lectins not yet
characterized
Salles et al. (2011)
Phalaris sp.
(Poaceae)
Tryptamine (alkaloid) Cantón et al. (2010)
P. angusta
P. angusta
P. aquatica
P. arundinacea
P. brachystachys
P. canariensis
P. paradoxa
P. caroliniana
P. minor
Prosopis juliflora Juliprosine and
juliprosopine (alkaloids)
Choudhary et al. (2005)
Ricinus communis
(leaves)
Ricinine (alkaloid) Worbs et al. (2011)
Solanum fastigiatum Alkaloids not yet
characterized
Rech et al. (2006)
capable of responding to neuronal injuries. These cells can change
morphology, alter the expression patterns of neurotrophic and/or
neurotoxic factors, or affect the association between these two
phenomena (Streit et al., 1999). Astrocytes and microglia respond
to all forms of neurological damage, including those induced by
toxicants undergoing activation, a phenomenon known as glio-
sis. Astrogliosis is associated with an altered phenotype due to
up-regulation of a large number of molecules (Eddleston and
Mucke, 1993; Cookson and Pentreath, 1994; Lefrançois et al.,
1997; Mead and Pentreath, 1998; Costa et al., 2002; Tardy, 2002),
including the accumulation of intermediate filaments containing
glial fibrillary acidic protein (GFAP). Several studies have shown
that GFAP is up-regulated after exposure to a diverse set of toxic
chemicals that includes kainic acid, mercury chloride, aluminum
chloride, toluene, ethanol, dibutyryl-cAMP, piperidine alkaloids,
and trimethyltin (Rataboul et al., 1989; Cookson and Pentreath,
1994; Mead and Pentreath, 1998; Harry et al., 2002; Hughes et al.,
2006; Silva et al., 2007). Although an increase in GFAP expression
can be associated with astrogliosis, reactions to physical damages,
and even neurodegeneration (Tardy, 1991; Coyle and Schwarcz,
2000; Costa et al., 2002), a reduction in GFAP expression can reflect
abnormal synaptogenesis and neurotransmission (O’Callaghan
and Jensen, 1992; Moises et al., 2002; Rajkowska et al., 2002).
Many toxic chemicals have undesirable characteristics because
of highly reactive metabolic products that are generated within
a target organ; this process is known as bioactivation. On rare
occasions, chemical bioactivation occurs within the liver, and the
toxic products are subsequently transported to the target organ
via circulation. In some species, brain tissue contains chemical-
activating enzymatic systems, which are unique to (or more active
in) this organ when compared with other tissues.
Cytochrome P450, which was named by Omura and Sato
(1962), has an important role in the detoxification of xenobiotics
for subsequent body elimination (Dutheil et al., 2007). In this
process, after contact between a foreign substance and the body,
two pathways are possible: the substance is removed, or it is bio-
transformed into an active compound that is capable of damaging
the body (Orellana and Guajardo, 2004). A variety of tissues have
the P450 system: liver, kidneys, lungs, skin, intestines, adrenal cor-
tex, testes, placenta, and brain, which is where the bioactivation of
compounds that cross the blood brain barrier (BBB) is especially
important (Orellana and Guajardo, 2004; Dutheil et al., 2007).
In addition to providing nutritional and structural support to
neurons in the CNS, one of the most important functions of astro-
cytes is to control the neurotoxins inside of the CNS. The brain
is the target of numerous toxic compounds, such as lipophilic
organic solvents and psychoactive drugs, which include amphet-
amines, benzodiazepines, and alkaloids, such as cocaine. These
substances can cross the BBB to exert their action at the cen-
tral level. The in situ metabolism of these substances leads to
local pharmacological modulation and the transformation of psy-
chotropic drugs into hydrophilic compounds by cytochrome P450
in the brain, which results in slower elimination (Ravindranath,
1998). A variety of enzymatic systems also have this capacity,
including the active CYP450 system (Coyle and Schwarcz, 2000;
Tardy, 2002). Astrocytes are the first line of defense against xenobi-
otics, and they express high levels of P450, which are approximately
two point seven times greater than the levels found in neurons,
which indicates that neuronal P450 does not function the same
as astrocytic P450. Studies of the brain’s bioactivation systems
have revealed that astrocyte-specific cytochrome P450-dependent
monooxygenases play a causative role in establishing the brain as
the target organ of several toxic agents (Meyer et al., 2001). The
P450 isoforms CYP1A1, CYP1A1/2, CYP2B1, CYP2B6, CYP2C11,
CYP2C,CYP2D6,CYP2E1,and CYP3A were determined in rat and
human astrocytes and considered functionally active (for review,
see Malaplate-Armand et al., 2004; Meyer et al., 2007).
TOXICOLOGICAL ASPECTS OF CROTALARIA
Plants of the Crotalaria genus grow abundantly in tropical and
subtropical zones and are adopted in popular medicine (Atal and
Sawhney, 1973; Mattocks, 1986). Because Crotalaria are invasive
plants, they are commonly found in grain plantations and pas-
tures (Cheeke, 1988), and they can be accidentally ingested by
humans and animals. In Brazil, approximately 40 species have
been found and are often eaten by animals, especially during
food shortages (Tokarnia et al. (2000)). These plants are rich in
pyrrolizidine alkaloids (PAs), which are the main toxins derived
from plants that are transferred to humans and animals (Mattocks,
1986; Huxtable, 1990). In animals, intoxications from Crotalaria
have been described in many countries (Boghossian et al., 2007),
including the Brazilian states of Mato Grosso do Sul (Lemos and
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Barros, 1998), Minas Gerais (Nobre et al., 1994), and Paraiba
(Nobre et al., 2004a,b, 2005). In the literature, there are descrip-
tions of intoxications in equines (Gibbons et al., 1953; Gardiner
et al., 1965), bovines (Barri and Adam, 1981), pigs (Peckham et al.,
1974; Souza et al., 1997), birds (Norton and O’Rourke, 1979), and
caprines (Barri et al., 1984). However, bovines and equines are
more susceptible to PA intoxication because they are 30–40 times
more susceptible to PA than ovines and caprines (Riet-Correa
et al., 2006). In Australia, Crotalaria retusa and C. crispata were
responsible for the disease known as “Kimberly horse disease” or
“walkabout disease” (Rose et al., 1957). In the semi-arid region
of Paraíba State in northeastern Brazil, cases of acute intoxication
in horses from C. retusa seeds occurred during the dry season
(Nobre et al., 2004a). In humans, intoxication from Crotalaria
can occur because of the consumption of grains contaminated by
plant seeds (Huxtable, 1989) and its use in popular medicine (Atal
and Sawhney, 1973). In India, for example, this plant is used for
the treatment of scabies and impetigo (a contagious skin disease
caused by Staphylococcus and Streptococcus; Damron and Jacob,
2001). Moreover, animals that feed on large quantities of Crota-
laria can eliminate the secondary metabolite through milk, which
is potentially dangerous for nurslings and individuals who ingest
contaminated milk (Panter and James, 1990).
However, it is well known that to exert their toxic effect, PAs
need to be metabolized by the hepatic and lung enzymatic P450
cytochrome system, which generates active metabolites, such as
dehydroalkaloids and pyrrols (Mattocks, 1986; Couet et al., 1996;
Kasahara et al., 1997). These metabolites might affect cellular
macromolecules, such as DNA and proteins, and form adducts
that can initiate an acute or chronic toxicity (Culvenor et al.,
1962). Monocrotaline is the major PA of C. retusa and is respon-
sible for the damaging effects observed in different animal species
(Cheecke, 1998). This alkali is primarily hepatotoxic and pneu-
motoxic, but nefrotoxic, cardiotoxic, fetotoxic, neurotoxic, and
carcinogenic effects are also related to MCT intoxication (Mat-
tocks, 1986; Ribeiro et al., 1993; Thomas et al., 1996; Cheecke, 1998;
Medeiros et al., 2000; Lin et al., 2001; Wang et al., 2005). In fact,
tissue-bound pyrrolic metabolites were detected in the liver, lung,
heart, and kidney after intraperitoneal injection of MCT (Yan and
Huxtable, 1995). Animal species that are particularly vulnerable,
such as horses, show classic liver fibrosis and neurological symp-
toms (Kimberly Horse Disease) that are associated with chronic
MCT exposure (Rose et al., 1957; Nobre et al., 2004a).
Studies of MCT metabolism in the liver and lungs of rats intox-
icated with MCT show that after the alkaloids are metabolized
by the P450 cytochrome system, they undergo dehydrogenation
to produce dehydromonocrotaline (DHMC), which is considered
a highly toxic compound (Lin et al., 2001; Wang et al., 2005).
In humans, both forms of detoxification, namely activation and
reaction, are catalyzed by the CYP 3A4 cytochrome (Miranda et al.,
1991). However, the resulting DHMC is unstable and can continue
through several metabolic pathways: (1) hydrolysis to 6,7-dihydro-
7-hydroxy-1-hydroxymethyl-5H-pyirrolizine (DHP), one of the
major active metabolites; (2) conjugation with glutathione (GSH)
in the liver to form 7-enamtiomers glutationil-6,7-dihydro-1-
hydroxymethyl-5H-pirrolizine (7-GS-DHP) and 7,9-DP-diGSH;
(3) nucleophilic alkylation of cellular macromolecules, which is a
process that highlights the toxic activity of DHMC; (4) or release
by circulation (Wang et al., 2005). MCT can also be biotrans-
formed by the P450 system to generate N-oxides, which can be
hydrolyzed into DHP, a major reactive metabolite, or converted
into a dehydroalkaloid. In the model of MCT-induced progres-
sive pulmonary hypertension (MCT-PH), some molecular targets
and pathways have been identified. In MCT-PH, the protein levels
of angiotensin-1 (Ang1), Ang2, endothelial nitric oxide synthase
(eNOS), inducible NOS (iNOS), heme oxygenase 1 (HO1), and
vascular endothelial growth factor (VEGF) were increased (Cho
et al., 2009). MCT-PH was also associated with increased expres-
sion of the matrix metalloproteinases (MMP)-2 and MMP-9 and
the protein psmad2, which is involved in transforming growth
factor-β (TGF-β) signaling (Zaiman et al., 2008). The protein
expression and activity of pulmonary soluble epoxide hydrolase
(sEH), which is involved in the metabolism of epoxyeicosatrienoic
acids (EETs), and the activity of pulmonary cytochrome P450
epoxygenase were impaired during MCT-PH in rats (Revermann
et al., 2009).
The presence of clinical neurological signs in animals intox-
icated with Crotalaria was initially associated with hepatic
encephalopathy because urea metabolism followed by hyper-
ammonemia was impossible (Cheeke, 1988; Nobre et al.,
2004b). Moreover, the metabolites derived from the alkaloids
trichodesmine and MCT, dehydrotrichodesmine and DHMC,
respectively, were found and measured in the brains of rats that
were experimentally intoxicated. These results demonstrated the
ability of these molecules to cross the BBB (Yan and Huxtable,
1995) and suggest that the neurological signs observed in intox-
icated animals result from efficient metabolism of the PA from
Crotalaria into active components of CNS cells. The hepatic P450
enzymatic systems that are involved in MCT metabolism related
to hepatic and pulmonary toxicity have been elucidated; however,
little is known about the pathways acting in the bioactivation of
these systems or about their direct contribution to brain toxicity.
UNDERSTANDING THE MCT METABOLISM OF ASTROCYTES
AND ITS RELATIONSHIP WITH NEUROTOXICITY
Primary cultures of astrocytes and neurons and co-cultures of
neuronal/glial cells, which are derived from the cortex of neona-
tal or embryonic rats or mice, are reliable in vitro models for
the biological and biochemical study of CNS cells in normal or
pathological conditions. These models have been used for decades
and have also been adopted as models for the study of neuro-
toxic substances (Booher and Sensenbrenner, 1972; Lesuisse and
Martin, 2001). To clarify the neurotoxic effects of MCT that was
extracted from C. retusa and its DHMC derivative, we conducted
in vitro studies in primary cultures of astrocytes or neurons and
in primary co-cultures of astrocytes/neurons obtained from the
cerebral cortex of Wistar rats.
Using an MTT test that measures mitochondrial function, we
noticed that MCT concentrations ranging from 0.1 to 500µM
did not induce cytotoxicity in these cells (Barreto et al., 2006). In
contrast, 1µM DHMC reduced cell viability 24 h after treatment,
and this reduction was more significant after 72 h of treatment
(Barreto et al., 2008). Metabolites, such as dehydroalkaloids and
pyrrols, might alkylate cellular macromolecules, such as proteins
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and DNA, to form adducts that can initiate an acute or chronic
toxicity (Culvenor et al., 1962). We also observed that both MCT
and DHMC induced changes in the expression levels and patterns
of GFAP, a major protein of the cytoskeleton in astrocytes. This
phenomenon was accompanied by severe phenotypic changes and
by hypertrophic astrocytes that characterized the cells reactive to
these alkaloids (Barreto et al., 2008). Moreover, in another study,
we investigated the action of MCT in glial cells of the GL-15 strain
and demonstrated that MCT and DHMC interfered with cellular
growth and induction of megalocytosis, induced significant down-
regulation of proteins associated with microtubules (MAPs), and
presented a genotoxic property (Silva-Neto et al., 2010).
The interactions between neurons and glial cells, such as astro-
cytes, are essential for synaptic properties (Volterra and Meldolesi,
2005), development, homeostasis, and detoxification of the CNS
(Letournel-Boulland et al., 1994); in contrast, neurons contribute
to the proliferation and survival of glial cells (Gomes et al.,
2001). Hence, we aimed to clarify the complexity of neurotoxic
phenomena induced by MCT in different populations of CNS cells;
thus, we recently conducted another study in co-cultures of neu-
rons/astrocytes and in primary cultures of isolated neurons. Using
MTT testing, we observed a reduction in cell viability after 72 h of
treatment with 100µM MCT. Under these conditions, the toxicity
of MCT was also demonstrated by determining the levels of lactate
dehydrogenase activity in the supernatants of co-cultures, which
indicated plasma membrane damage had occurred. However, the
changes in cell viability were not observed in primary cultures
of isolated neurons. One of the main features of astrogliosis is
an increase in GFAP expression (Tardy, 2002). In our system of
co-cultures, when both astrocytes and neurons were in contact,
vacuolization, and an increase in the cell body of astrocytes were
observed; an increase in GFAP expression after 72 h treatment
with 100µM MCT was also observed and indicated astrogliosis.
The resistance of astrocytes to MCT toxicity in astrocytes isolated
FIGURE 1 |The proposed metabolic activation and detoxification
pathways of monocrotaline in astrocytes interacting with neurons.
CYP, enzyme of the cytochrome P450 complex; GSH, glutathione;
DHMC, dehydromonocrotaline; DHP, 6,7-dihydro-7-hydroxy-1-
hydroxymethyl-5H-pyrrolizine; 7-GSH-DHP, 7-glutationil-6,
7-dihydro-1-hydroxymethyl-5H-pyrrolizine; 7.9-7.9-DHP-diGSH
diglutationil-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine; NuS, nucleophilic
biological macromolecules.
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from primary cultures, observed by Barreto et al. (2006), can be
understood as the result of their limited capacity in metabolizing
xenobiotics, which must be restored when neurons and glia inter-
act. Mingatto et al. (2007) worked with isolated mitochondria
from rat liver and observed a decrease in the NADH oxidase activ-
ity of the respiratory chain complex I. Thus, MCT interference in
mitochondrial function and toxicity might result from the gen-
eration of active metabolites, such as DHMC, by astrocytes when
these cells interact with neurons. Moreover, it is known that when
large quantities of certain toxic compounds circulate, detoxifying
enzymes, such as cytochrome P450 (from the smooth cytoplasmic
reticulum), are produced, which causes folding of the organellar
surface area (Alberts et al., 2002). Once the toxin disappears, the
excess smooth endoplasmic reticulum membrane is removed by a
process dependent on lysosomes, called autophagocytosis. Cyto-
plasmic vacuoles were evident in co-cultures of astrocytes/neurons
(Pitanga et al., 2011) but not in primary cultures of astrocytes
treated with MCT (Barreto et al., 2006), which confirms the
hypothesis that metabolic properties of MCT are dependent on
interactions between neurons and glia.
In association with MAPs, neuronal β-tubulin III protein,
which is considered the main structural protein of neurons (Lesu-
isse and Martin, 2001), integrates a dynamic network and plays
a crucial role in key biological processes, such as cell division
and intracellular transport (Guzik and Goldstein, 2004). By apply-
ing immunocytochemistry in co-cultures exposed to 10–100µM
MCT, we found that MCT disrupts β-tubulin III staining, which
suggested that the polymerization of this protein failed in neurons.
Moreover, by western blot analysis, we observed a strong decrease
in the β-tubulin III expression in protein extracts, which indi-
cated protein destabilization had occurred (Pitanga et al., 2011).
These findings support the theory that the neuronal β-tubulin III
cytoskeletal protein is a molecular target of MCT or its metabo-
lites, which might interfere with the dynamics of stabilization of
microtubular proteins.
As previously discussed, the cytotoxicity of MCT in hepato-
cytes is due to the generation of DHMC by the cytochrome P450
enzyme complex; the resulting DHMC, then binds to GSH and
causes its depletion (Lin et al., 2002; Wang et al., 2005). Studies
indicate that GSH protects glial cells from oxidative stress, and
GSH depletion causes several biochemical and molecular changes
that might be related to neurological disorders (Lee et al.,2010). We
also observed that treatment with 100µM MCT depleted GSH in
co-cultures of astrocytes/neurons and that the GSH depletion was
reversed when the cytochrome P450 enzymatic system was inhib-
ited by cimetidine, a potent inhibitor of hepatic cytochrome P450
(Chang et al. (1992)). These findings indicate that GSH depletion
is dependent on the metabolism and synthesis of active metabo-
lites via the P450 system and that this phenomenon is involved in
MCT-induced neurotoxicity (Pitanga et al., 2011). Taken together,
these in vitro studies of primary rat cultures of astrocytes or neu-
rons provide new information on the mechanisms of MCT toxicity
in different cell populations in the CNS and their relationship to
neurological phenomena observed in intoxicated animals.
To induce hepatotoxicity and pneumotoxicity, PAs, such as
MCT, must be metabolized into active metabolites by the P450
system of the liver or lungs (Lin et al., 2001; Wang et al., 2005).
Because of this requirement and our findings, we propose a meta-
bolic mechanism for MCT in isolated astrocytes and in interaction
with neurons. We propose that MCT acts through an efficient
P450 system to generate greater amounts of active metabolites,
including DHMC, monocrotaline-N-oxide, and derivatives, such
as DHP; these active metabolites then induce cellular toxicity or
are detoxified by their conjugation with GSH (Figure 1). The
pyrrolic metabolite DHMC is a highly unstable, intermediate reac-
tive metabolite and that can: (i) undergo hydrolysis to form DHP
and subsequently form the DHP-derived DNA adducts by a reac-
tion with DNA; (ii) bind to cellular DNA and subsequently be
hydrolyzed to form the DHP-derived DNA adducts; or (iii) conju-
gate with nucleophilic biological macromolecules, such as cellular
proteins, and with GSH. We predict that the reversion of cellu-
lar toxicity in the primary cultures of astrocytes/neurons after
exposure to the potent CYP inhibitor cimetidine indicates that
P450 metabolism and DHMC,DHP,and/or N-oxide formation are
essential for MCT toxicity in CNS cells. Finally, because MCT and
DHMC target specific neural cytoskeletal proteins, such as GFAP
and β-tubulin III, and because of our biological profiles of PAs,
mainly MCT and their derivatives, these natural products should
be considered potential lead compounds for drug development to
treat CNS disorders, such as cancer.
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